Order Article Reprints

Elhini SH, Wahsh EA, Elberry AA, El Ameen NF, Abdelfadil Saedii A, Refaie SM, Elsayed AA, Rabea HM. The Impact of an SGLT2 Inhibitor versus Ursodeoxycholic Acid on Liver Steatosis in Diabetic Patients. Pharmaceuticals. 2022; 15(12):1516. https://doi.org/10.3390/ph15121516

Elhini, Sahar H., Engy A. Wahsh, Ahmed A. Elberry, Nadia F. El Ameen, Ahmed Abdelfadil Saedii, Shereen Mahmoud Refaie, Asmaa A. Elsayed, and Hoda M. Rabea. 2022. "The Impact of an SGLT2 Inhibitor versus Ursodeoxycholic Acid on Liver Steatosis in Diabetic Patients" Pharmaceuticals 15, no. 12: 1516. https://doi.org/10.3390/ph15121516

Elhini, S. H., Wahsh, E. A., Elberry, A. A., El Ameen, N. F., Abdelfadil Saedii, A., Refaie, S. M., Elsayed, A. A., & Rabea, H. M. (2022). The Impact of an SGLT2 Inhibitor versus Ursodeoxycholic Acid on Liver Steatosis in Diabetic Patients. Pharmaceuticals, 15(12), 1516. https://doi.org/10.3390/ph15121516